| Dr John T Barr, OD | |
|
2567 Housley Rd, Annapolis, MD 21401-6751 | |
| (410) 224-2306 | |
| (410) 224-0206 |
| Full Name | Dr John T Barr |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 36 Years |
| Location | 2567 Housley Rd, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497884191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA-1003 (Maryland) | Primary |
| Provider Name | Aurora Vision Group, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144372103 PECOS PAC ID: 7911173414 Enrollment ID: O20120105000137 |
News Archive
A novel set of custom-designed "molecular beacons" allows scientists to monitor gene expression in living populations of stem cells as they turn into a specific tissue in real-time. The technology, which Brown University researchers describe in a new study, provides tissue engineers with a potentially powerful tool to discover what it may take to make stem cells transform into desired tissue cells more often and more quickly.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
CBS News "has learned that up to 60,000 people have cancelled their AARP memberships since July 1, angered over the group's" support of Democratic health care proposals. "Many are switching to the American Seniors Association, a group that calls itself the conservative alternative … 'I think that probably the seniors are most upset with cuts in Medicare,' said ASA President Stuart Barton. The American Seniors Association is flat-out against President Obama's plan, which calls for $313 billion dollars in Medicare cuts over ten years ... Last week, Obama told a town meeting in Portsmouth, NH, 'We have the AARP on board because they know this is a good deal for our seniors'" (Attkisson, 8/17).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John T Barr, OD 2567 Housley Rd, Annapolis, MD 21401-6751 Ph: (410) 224-2306 | Dr John T Barr, OD 2567 Housley Rd, Annapolis, MD 21401-6751 Ph: (410) 224-2306 |
News Archive
A novel set of custom-designed "molecular beacons" allows scientists to monitor gene expression in living populations of stem cells as they turn into a specific tissue in real-time. The technology, which Brown University researchers describe in a new study, provides tissue engineers with a potentially powerful tool to discover what it may take to make stem cells transform into desired tissue cells more often and more quickly.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
CBS News "has learned that up to 60,000 people have cancelled their AARP memberships since July 1, angered over the group's" support of Democratic health care proposals. "Many are switching to the American Seniors Association, a group that calls itself the conservative alternative … 'I think that probably the seniors are most upset with cuts in Medicare,' said ASA President Stuart Barton. The American Seniors Association is flat-out against President Obama's plan, which calls for $313 billion dollars in Medicare cuts over ten years ... Last week, Obama told a town meeting in Portsmouth, NH, 'We have the AARP on board because they know this is a good deal for our seniors'" (Attkisson, 8/17).
› Verified 3 days ago
Dr. Ryan Shaun Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 | |
Jonathan Jacesko, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. David A Byman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. Elizabeth C Mcmunn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-4378 | |
Dr. Jay Thompson Rorick, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 888 Bestgate Road, Suite 102, Annapolis, MD 21401 Phone: 410-571-7325 Fax: 410-571-7301 | |
Wenny Tan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 | |
Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |